CTOs on the Move

Kaberline Healthcare

www.kaberline.com

 
Kaberline Healthcare is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 5K-10K
  • Annual Revenue: $1-10 Million
  • www.kaberline.com
  • 11642 Lilburn Park Rd
    Saint Louis, MO USA 63146
  • Phone: 314.994.3880

Executives

Name Title Contact Details

Similar Companies

AOS Research Inc

AOS Research Inc is a Wilmington, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HumanTouch

Human Touch is the leading provider of high-quality, innovative lifestyle products, massage chairs, and experiences that deliver life-changing benefits. We have been making people feel better for over 35 years by developing state-of-the-art massage products containing patented massage systems that replicate techniques used by massage professionals. Our wellness solutions help to reduce muscle tension and pain caused by today`s hectic lifestyle so that people can do what they do - better. Combining advanced technology and attractive design, Human Touch innovations are perfectly suited for today`s modern and traditional living spaces. Our customers include serious athletes looking to recover from intensive training, thousands of chiropractors who integrate a therapeutic massage on a Human Touch massage chair into their professional services, back pain sufferers looking to reduce their aches and pains, and everyday people looking for a respite from the stress of today`s lifestyle.

Radiology Associates of North Texas

Radiology Associates of North Texas is a private practice provider of high quality diagnostic and interventional radiology services. With over 240 Texas based radiologists, our practice provides a level of service and subspecialty expertise to North Te...

Next Health

Next Health is an immunity health and wellness center specializing in IV Therapy, Cryotherapy, NAD Therapy and COVID Testing. Walk-ins are welcome.

Envisia Therapeutics

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.